𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: Results from the FAMOUS study

✍ Scribed by P.J., Goebell; A., Münch; L., Müller; H.J., Hurtz; M., Koska; S., Busies; N., Marschner

Book ID
122176922
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
522 KB
Volume
32
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and oxaliplatin in the treat
Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma : Final results of a single-institution Phase II study
✍ Camillo Porta; Matteo Zimatore; Ilaria Imarisio; Anna Natalizi; Andrea Sartore-B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 3 views

## Abstract ## BACKGROUND Currently, there is no standard treatment for patients with advanced renal cell carcinoma (RCC) who do not experience a response to first‐line immunotherapy. In the current Phase II study, the authors explored the antitumor activity of a combination of gemcitabine and oxa